DexCom (DXCM) Stock
NSQ · DXCM
89.17
Fundamentals
Market cap
$33.72B
Price / Earnings ratio
33.7x
Price / Sales ratio
6.8x
Price / Book ratio
12.9x
Return on assets
0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About DexCom
Dexcom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.
SectorHealthcare
IndustryMedical Devices
Employees11,000
CEOMr. Jacob Steven Leach
IPO DateApr 14, 2005
HeadquartersSan Diego, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Kevin Ronald Sayer | Executive Chairman of the Board | 1958 |
| Mr. Jacob Steven Leach | President, CEO & Director | 1978 |
| Mr. Michael Jon Brown J.D. | Executive VP, Chief Legal & Compliance Officer | 1970 |
| Ms. Sadie M. Stern | Executive VP, Chief People & Culture Officer | 1975 |
| Mr. Jon Coleman | Executive VP & Chief Commercial Officer | 1964 |
| Mr. Peter Simpson | Executive VP & CTO | — |
| Mr. Sean Christensen | Vice President of Finance and Investor Relations | — |
| Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development | 1981 |
| Keri Leone | Senior Director of Global Medical Science & Education | — |
| Christine Pospisil | Director of Medical Science & Education | — |
Fundamentals
Valuation
Market cap$33.72B
Price-to-sales ratio6.79
Price-to-book value12.86
Price-earnings ratio33.70
Return on Equity34.00%
Return on Sales0.25%
Return on Assets0.13%
PEG ratio1.28
Earnings Per Share
Earnings Per Share$2.59
Income Statement
Average volume4,027,727
EBITDA$1.48B
1 year high (52w)$92.59
1 year low (52w)$54.11
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



